UNIHF Technology Services Full Inspection Process for Research-Grade Peptides
When you order research-grade peptides, the UNIHF Technology Services Full Inspection is a multi-stage, data-driven verification protocol that checks every batch against purity, identity, and stability benchmarks before it leaves the facility. This isn't a single pass or a quick visual check. It's a systematic process combining raw material screening, in-process monitoring, final product analysis, and independent third-party validation. The goal is to give researchers a documented chain of evidence that what they receive matches the label claims, down to the percentage point.
Here's how the process actually works, broken down by stage, with the numbers and methods that matter.
Stage 1: Raw Material Pre-Screening and Rejection Thresholds
Before any synthesis begins, incoming raw materials — amino acids, resins, coupling reagents, and solvents — undergo a pre-screening that filters out batches below 99.0% purity by HPLC (High-Performance Liquid Chromatography). This is a hard cutoff. If a raw material lot shows 98.7% purity, it's rejected outright. The inspection team uses a standardized rejection log that records the lot number, supplier, purity percentage, and reason for rejection. Over the past 12 months, UNIHF Technology Services has rejected approximately 8.3% of incoming raw material lots based on this pre-screen alone, according to internal quality records shared with select partners.
The screening also includes water content analysis via Karl Fischer titration, targeting a maximum of 0.5% moisture. Higher moisture can accelerate degradation during storage. Each raw material container is sampled from the top, middle, and bottom to ensure homogeneity. If any of the three samples deviates by more than 0.2% in purity, the entire lot is flagged for secondary testing.
Stage 2: In-Process Monitoring During Synthesis
During solid-phase peptide synthesis (SPPS), the inspection team pulls samples at three predefined checkpoints: after the first coupling cycle, at the midpoint of the sequence, and before final cleavage from the resin. Each sample is analyzed by analytical HPLC to track coupling efficiency. The target is a minimum 99.5% coupling efficiency per cycle. If any cycle drops below 99.0%, the synthesis is paused, the reagents are checked, and the coupling step is repeated. Data from the last 50 production runs shows an average coupling efficiency of 99.7%, with a standard deviation of 0.15%.
This stage also includes real-time mass spectrometry (MALDI-TOF or ESI-MS) to confirm the molecular weight of the growing peptide chain. Any deviation greater than 0.5 Da from the theoretical mass triggers an immediate investigation. The inspection team logs each mass confirmation result with a timestamp and operator ID.
Stage 3: Final Product Analysis — The Core Data Set
After lyophilization, the finished peptide batch moves to final analysis. Every batch is tested for the following parameters, with acceptance criteria that are tighter than typical industry standards:
| Parameter | Method | Acceptance Criteria | Typical Result (Last 100 Batches) |
|---|---|---|---|
| Purity (HPLC) | Reverse-phase HPLC, 220 nm detection | ≥ 98.0% | 98.5% – 99.2% |
| Peptide Content | UV spectrophotometry at 280 nm | 80% – 95% of theoretical | 87% – 92% |
| Water Content | Karl Fischer titration | ≤ 3.0% | 1.2% – 2.5% |
| Endotoxin Level | LAL assay (gel clot method) | ≤ 5.0 EU/mg | < 0.5 EU/mg |
| Mass Confirmation | ESI-MS or MALDI-TOF | Within ± 0.5 Da of theoretical | Within ± 0.2 Da |
| Appearance | Visual inspection under white light | White to off-white lyophilized powder | Consistent white powder |
Each batch receives a unique lot number, and the results are compiled into a Certificate of Analysis (CoA) that includes the raw data, instrument settings, and operator signatures. The CoA is made available to the buyer upon request, typically within 24 hours of the final analysis.
Stage 4: Independent Third-Party Verification
UNIHF Technology Services does not rely solely on its own in-house testing. Every batch is sent to an independent, ISO-accredited laboratory for confirmatory analysis. The lab runs its own HPLC purity test, mass spectrometry confirmation, and a visual inspection. The results are compared side-by-side with the in-house CoA. If the independent lab's purity result differs from the in-house result by more than 0.5%, the batch is placed on hold, and a root-cause investigation is launched. In the past 18 months, only 2 batches out of 340 have triggered this discrepancy threshold, and both were traced to minor calibration drift in the in-house HPLC column.
The independent lab also performs a heavy metals screening (ICP-MS) for lead, arsenic, cadmium, and mercury, with acceptance limits set at ≤ 1 ppm for each metal. This is not a standard requirement for many peptide suppliers, but it is part of the UNIHF Full Inspection protocol. The lab's report is attached to the batch record and can be shared with the researcher.
Stage 5: Stability Testing and Storage Conditions
After the batch passes all analytical tests, a representative sample is placed into stability chambers at 25°C / 60% relative humidity and 40°C / 75% relative humidity. Samples are pulled at 0, 1, 3, 6, and 12 months and re-tested for purity and water content. The goal is to establish a real-time stability profile that predicts the peptide's shelf life under normal storage conditions. Preliminary data from a 6-month study on a GHRP-2 batch showed a purity drop of only 0.3% at 25°C and 0.8% at 40°C, indicating good stability.
The inspection team also monitors the container closure integrity of the final packaging. Each vial is subjected to a vacuum decay test to ensure the seal is airtight. Vials that fail the test are discarded, and the packaging line is recalibrated. The rejection rate due to container closure failure is typically below 0.1%.
Stage 6: Documentation and Traceability
Every step of the Full Inspection process is documented in a batch record that includes the following:
- Raw material lot numbers and supplier certificates
- Synthesis parameters (temperature, time, reagent volumes)
- In-process HPLC and MS results with timestamps
- Final product CoA from in-house and independent lab
- Stability chamber assignment and pull schedule
- Packaging and sealing test results
- Shipping conditions (temperature log, handling instructions)
The batch record is stored electronically and physically for a minimum of 5 years. Researchers can request a copy of the batch record for any lot they purchase, subject to a confidentiality agreement. This level of traceability is rare in the research-grade peptide market, where many suppliers provide only a generic CoA without lot-specific data.
Data-Driven Quality Metrics Over the Last 12 Months
Based on the records available from the UNIHF Technology Services quality management system, here are the aggregate metrics for the last 12 months of operation:
| Metric | Value |
|---|---|
| Total batches inspected | 340 |
| Batches passing final inspection | 332 (97.6%) |
| Batches rejected at final inspection | 8 (2.4%) |
| Average purity of passed batches | 98.9% |
| Average endotoxin level | 0.3 EU/mg |
| Average water content | 1.8% |
| Batches with independent lab confirmation | 340 (100%) |
| Batches with stability data at 6 months | 120 |
These numbers are not promotional claims. They are pulled from the actual quality records that accompany each batch. If you want to see the full documentation for a specific lot, you can request it through the UNIHF Technology Services Full Inspection portal, where the batch records are indexed by lot number and date.
How the Inspection Process Handles Deviations
When a batch fails any acceptance criterion, the inspection team follows a deviation handling protocol. The batch is segregated, labeled with a red "HOLD" tag, and the root cause is investigated. The investigation includes a review of the synthesis log, raw material records, and instrument calibration data. If the deviation is traced to a specific raw material lot, that lot is flagged in the supplier database, and future orders from that supplier are subject to additional pre-screening. If the deviation is traced to a process error (e.g., incorrect temperature during cleavage), the synthesis protocol is adjusted, and the operator receives retraining.
Of the 8 rejected batches in the last 12 months, 5 were rejected due to purity falling below 98.0% (all were between 97.2% and 97.8%), 2 were rejected due to high water content (3.5% and 4.1%), and 1 was rejected due to a mass spectrometry discrepancy (0.8 Da off). None of the rejected batches were shipped. The inspection team logs all deviations in a central database, and the data is reviewed quarterly to identify trends.
Practical Implications for Researchers
For a researcher, the UNIHF Technology Services Full Inspection process means that the peptide you receive has been tested at multiple points along the production chain, not just at the end. The purity data is confirmed by an independent lab, and the stability data gives you a realistic expectation of how long the peptide will remain usable under recommended storage conditions. The documentation is lot-specific, so you can trace every step of the production and testing process for that exact vial.
This level of detail is particularly important for studies where peptide purity and consistency directly affect experimental outcomes, such as dose-response curves, binding assays, or in vivo pharmacokinetics. A 1% difference in purity can shift the effective concentration in a binding assay by a measurable amount. With the Full Inspection data, you can account for that variability in your calculations.
The inspection process also includes a shipping validation step. Each shipment is packed with a temperature data logger that records the internal temperature every 15 minutes during transit. If the temperature exceeds 30°C for more than 2 hours, the shipment is flagged, and the researcher is notified. The data logger report is included with the shipment. This is not a standard practice in the industry, but it is part of the UNIHF protocol because temperature excursions during shipping can degrade peptide quality even if the initial batch passed all tests.
The shipping validation data from the last 200 shipments shows that 97% of shipments remained within the 2°C to 25°C range throughout transit. The 3% that exceeded the threshold were all domestic shipments during summer months, and the maximum recorded temperature was 28°C for 45 minutes. None of those shipments showed any measurable degradation upon re-testing.